Tumor Necrosis in Hepatocellular Carcinoma—Unfairly Overlooked?
Authors:
- 22 November 2020
- journal article
- editorial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (2) , 600-601
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular CarcinomaAnnals of Surgical Oncology, 2020
- Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled TrialAnnals of Surgical Oncology, 2020
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 2020
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2018
- Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysisOncotarget, 2015
- Tumor necrosis is a new promising prognostic factor in colorectal cancerHuman Pathology, 2010
- Pathologic Variables Predictive of Breast Events in Patients With Ductal Carcinoma In SituAmerican Journal of Clinical Pathology, 2007
- Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessCancer, 2005